- Investing Ideas
- Belgian Large Cap High Growth Potential
Belgian Large Cap High Growth Potential
Results
5
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
5 companies
argenx
Market Cap: €43.4b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€709.00
7D
-1.3%
1Y
14.5%
Elia Group
Market Cap: €13.7b
Develops and operates as a transmission system operator in Belgium and Germany.
ELI
€125.90
7D
1.9%
1Y
98.1%
Groupe Bruxelles Lambert
Market Cap: €10.1b
Invests in a portfolio of industrial, consumer goods, and business service companies operating in various sectors in Belgium, other European countries, North America, and internationally.
GBLB
€83.90
7D
3.0%
1Y
25.2%
UCB
Market Cap: €50.3b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€265.00
7D
1.5%
1Y
39.9%
D'Ieteren Group
Market Cap: €10.5b
Operates as an investment company in Belgium, France, rest of Europe, and internationally.
DIE
€197.90
7D
0.5%
1Y
24.5%